Effect of the rs12249854 Polymorphism in the HECTD2 Gene and Selected Clinical Variables on the Response to Intradetrusor Injection of Botulinum Neurotoxin Type a in Female Patients with Overactive Bladder: A Single-Center Prospective Study
International Journal of Molecular Sciences · 26.10.2026 · 27 (21) · 9571
DOI: 10.3390/ijms27219571 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.10.2026. Verfasst von Sylwester Michał Ciećwież und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Perinatology, Obstetrics and Gynecology, Pomeranian Medical University, 70-204 Szczecin, Poland. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive, Botulinum Toxins, Type A, Polymorphism, Single Nucleotide, Ubiquitin-Protein Ligases. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The HECTD2:rs12249854 polymorphism may be associated with a weaker response to an intradetrusor injection of botulinum neurotoxin type A (BoNT/A) in patients with overactive bladder (OAB). This prospective study analyzed the link between the HECTD2:rs12249854 polymorphism and the response to BoNT/A treatment in 156 OAB patients, based on changes in urodynamic parameters and ICIQ-OAB and ICIQ-LUTS-QoL scores six months after the injection. BoNT/A treatment contributed to improvements in all parameters except the average flow rate. Wild-type homozygotes (TT, n = 137) differed from TA heterozygotes (n = 19) solely in terms of pretreatment ICIQ-OAB Part A and ICIQ-LUTS-QoL Part A scores, both of which were higher in the heterozygotes. Thus, the HECTD2:rs12249854 polymorphism does not appear to be associated with the response to BoNT/A treatment. Patients with neurogenic OAB (n = 60) had a higher pretreatment detrusor pressure at maximum flow than those with idiopathic OAB (n = 96), but this difference was no longer observed after BoNT/A treatment. Good responders to the BoNT/A injection (defined as at least 50% decrease in the ICIQ-LUTS-QoL Part A score, n = 50) had a higher body mass index and parity and a lower pretreatment maximum flow rate than poor responders (n = 106). Before formulating any definitive conclusions, the results of this exploratory study should be verified in an adequately powered multicenter cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Perinatology, Obstetrics and Gynecology, Pomeranian Medical University, 70-204 Szczecin, Poland.
- Department of Clinical and Molecular Biochemistry, Pomeranian Medical University, 70-204 Szczecin, Poland.
- Department of Pharmacology and Toxicology, University of Zielona Góra, 65-417 Zielona Góra, Poland.
- Department of Gynecology, Evangelisches Krankenhaus Hagen, 58135 Hagen, Germany.
ORCID-Profile: Sylwester Michał Ciećwież, Agnieszka Boroń, Dariusz Kotlęga, Jacek Kociszewski, Andrzej Ciechanowicz
Zitieren
APA
Ciećwież, S. M., Lewandowska, K., Boroń, A., Kotlęga, D., Kociszewski, J., & Ciechanowicz, A. (2026). Effect of the rs12249854 Polymorphism in the HECTD2 Gene and Selected Clinical Variables on the Response to Intradetrusor Injection of Botulinum Neurotoxin Type a in Female Patients with Overactive Bladder: A Single-Center Prospective Study. International Journal of Molecular Sciences, 27(21), 9571. https://doi.org/10.3390/ijms27219571
Vancouver
Ciećwież SM, Lewandowska K, Boroń A, Kotlęga D, Kociszewski J, Ciechanowicz A. Effect of the rs12249854 Polymorphism in the HECTD2 Gene and Selected Clinical Variables on the Response to Intradetrusor Injection of Botulinum Neurotoxin Type a in Female Patients with Overactive Bladder: A Single-Center Prospective Study. International Journal of Molecular Sciences. 2026;27(21):9571. doi:10.3390/ijms27219571
BibTeX
@article{Ciewie2026,
author = {Ciećwież, Sylwester Michał and Lewandowska, Klaudyna and Boroń, Agnieszka and Kotlęga, Dariusz and Kociszewski, Jacek and Ciechanowicz, Andrzej},
title = {Effect of the rs12249854 Polymorphism in the HECTD2 Gene and Selected Clinical Variables on the Response to Intradetrusor Injection of Botulinum Neurotoxin Type a in Female Patients with Overactive Bladder: A Single-Center Prospective Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9571},
doi = {10.3390/ijms27219571}
}
EUVIMED